Nancy Knight Morin

age ~55

from Trenton, NJ

Get Report

Also known as:

Connected to:

Nancy Morin Phones & Addresses

Flora Of North America North Of Mexico: Magnoliophyta Magnoliidae And Hamamelidae
view source
Author:

Nancy R. Morin
ISBN #:

0195112466

Npy Y5 Receptor Antagonists
view source
US Patent:

6495559, Dec 17, 2002
Filed:

Jun 29, 2001
Appl. No.:

09/896940
Inventors:

Douglas J. MacNeil - Westfield NJ
Lihu Yang - Edison NJ
Nancy R. Morin - Cranford NJ
Takehiro Fukami - Ibaraki, JP
Akio Kanatani - Ibaraki, JP
Takahiro Fukuroda - Ibaraki, JP
Yasuyuki Ishii - Saitama, JP
Masaki Ihara - Ibaraki, JP
Assignee:

Merck Co., Inc. - Rahway NJ
Banyu Pharmaceutical Co., Ltd. - Tokyo
International Classification:

C07D22120
US Classification:

514278, 544330, 544405, 546 18
Abstract:

Compounds of general structural formula I such as that shown in structural formula II are selective NPY Y5 receptor antagonists, useful in the treatment of obesity and the complications associated therewith.

Spiro-Indolines As Y5 Receptor Antagonists
view source
US Patent:

6638942, Oct 28, 2003
Filed:

Aug 26, 2002
Appl. No.:

10/228250
Inventors:

Douglas J. MacNeil - Westfield NJ
Lihu Yang - Edison NJ
Nancy R. Morin - Cranford NJ
Takehiro Fukami - Ibaraki, JP
Akio Kanatani - Ibaraki, JP
Takahiro Fukuroda - Ibaraki, JP
Yasuyuki Ishii - Saitama, JP
Masaki Ihara - Ibaraki, JP
Assignee:

Merck Co., Inc. - Rahway NJ
Banyu Pharmaceutical Co., Ltd. - Tokyo
International Classification:

C07D47110
US Classification:

514278, 546 15, 544230, 564168, 548411
Abstract:

Compounds of general structural formula I are selective NPY Y5 receptor antagonists, useful in the treatment of obesity and the complications associated therewith.

Spiro-Indolines As Y5 Receptor Antagonists
view source
US Patent:

20040063942, Apr 1, 2004
Filed:

Jul 21, 2003
Appl. No.:

10/624414
Inventors:

Douglas MacNeil - Westfield NJ, US
Lihu Yang - Edison NJ, US
Nancy Morin - Cranford NJ, US
Takehiro Fukami - Ibaraki, JP
Akio Kanatani - Ibaraki, JP
Takahiro Fukuroda - Ibaraki, JP
Yasuyuki Ishii - Saitama, JP
Masaki Ihara - Ibaraki, JP
International Classification:

C07D487/12
C07D471/12
US Classification:

544/230000, 546/015000, 546/016000
Abstract:

Compounds of general structural formula I such as that shown in structural formula II are selective NPY Y5 receptor antagonists, useful in the treatment of obesity and the complications associated therewith.

Dna Encoding 1,3 Beta-D Glucan Synthase Subunits
view source
US Patent:

58213538, Oct 13, 1998
Filed:

Aug 1, 1996
Appl. No.:

8/619554
Inventors:

Cameron M. Douglas - Piscataway NJ
Gary L. Chrebet - Princeton NJ
Joseph Clemas - Metuchen NJ
Mohammed El-Sherbeini - Westfield NJ
Forrest Foor - New York NY
Jennifer Nielsen Kahn - East Brunswick NJ
Rosemarie Kelly - Westfield NJ
Jean A. Marrinan - Somerset NJ
Nancy R. Morin - Cranford NJ
Janet C. Onishi - Westfield NJ
Stephen Authur Parent - Cranbury NJ
Naasa M. Ramadan - Westfield NJ
Elizabeth A. Register - Scotch Plains NJ
Assignee:

Merck & Co., Inc. - Rahway NJ
International Classification:

C07H 2104
C12N 115
C12P 2102
C07K 14395
US Classification:

536 2374
Abstract:

DNA molecules encoding proteins involved in biosynthesis of 1,3-beta-D glucan are identified, cloned, expressed and used in in vitro assays to screen for antifungal compounds, including compounds that affect cell wall biosynthesis. The invention includes but is not limited to the purified DNA molecules, assays employing the DNA molecules, proteins encoded by the DNA molecules, cells expressing the DNA molecules and altered forms of the molecules.

Spiro-Indolines As Y5 Receptor Antagonists
view source
US Patent:

61911607, Feb 20, 2001
Filed:

Nov 8, 1999
Appl. No.:

9/436120
Inventors:

Douglas J. MacNeil - Westfield NJ
Lihu Yang - Edison NJ
Nancy R. Morin - Cranford NJ
Takehiro Fukami - Ibaraki, JP
Akio Kanatani - Ibaraki, JP
Takahiro Fukuroda - Ibaraki, JP
Yasuyuki Ishii - Saitama, JP
Masaki Ihara - Ibaraki, JP
Assignee:

Merck & Co., Inc. - Rahway NJ
Banyu Pharmaceutical Co., Ltd. - Tokyo
International Classification:

A61K 31495
A61K 3140
C07D23902
C07D20954
C07D27760
US Classification:

514409
Abstract:

Compounds of the general structural formula I ##STR1## are selective NPY Y5 receptor antagonists. The compounds and compositions of the present invention are useful in the treatment of obesity and complications associated therewith.

Spiro-Indolines As Y5 Receptor Antagonists
view source
US Patent:

63132982, Nov 6, 2001
Filed:

Sep 7, 2000
Appl. No.:

9/656698
Inventors:

Lihu Yang - Edison NJ
Douglas J. MacNeil - Westfield NJ
Nancy R. Morin - Cranford NJ
Takehiro Fukami - Ibaraki, JP
Takahiro Fukuroda - Ibaraki, JP
Akio Kanatani - Ibaraki, JP
Yasuyuki Ishii - Saitama, JP
Masaki Ihara - Ibaraki, JP
Assignee:

Merck & Co., Inc. - Rahway NJ
International Classification:

C07D47120
C07D47110
C07D22120
A61K 31438
A61K 31499
US Classification:

546 17
Abstract:

Compounds of general structural formula I such as that shown in structural formula II ##STR1## are selective NPY Y5 receptor antagonists, useful in the treatment of obesity and the complications associated therewith.